Around age 50, the brain undergoes a dramatic shift where blood monocytes invade and replace original microglia cells, triggering inflammation and memory loss. This process, driven by epigenetic changes and 3D genome reorganization, was only recently discovered through advanced multi-omics techniques and contradicts decades of assumptions about linear brain aging.

• At midlife, astrocytes in the hippocampus fail and lose integrity, allowing inflammatory monocytes from the bloodstream to infiltrate the brain and transform into replacement microglia (Micro2 cells) that produce damaging cytokines.
• The replacement process is unique to humans, happens faster in men than women, and occurs across multiple brain regions including the cerebellum and prefrontal cortex—not just the hippocampus.
• Paradoxically, certain blood mutations (CHIP) in brain microglia reduce Alzheimer's plaques by ~50%, suggesting peripheral immune cell therapy could become a new prevention strategy without the risks of direct brain implantation.